Refractory gastroesophageal reflux disease.

Abstract

Gastroesophageal reflux disease (GERD) is a condition that develops when the reflux of stomach contents into the esophagus causes troublesome symptoms, esophageal injury, and/or complications. Use of proton pump inhibitors (PPI) remains the standard therapy for GERD and is effective in most patients. Those whose symptoms are refractory to PPIs should be evaluated further and other treatment options should be considered, according to individual patient characteristics. Response to PPIs could be total (no symptoms), partial (residual breakthrough symptoms), or absent (no change in symptoms). Patients experiencing complete response do not usually need further management. Patients with partial response can be treated surgically or by using emerging endoscopic therapies. Patients who exhibit no response to PPI need further evaluation to rule out other causes.

• Authors: Charumathi Raghu Subramanian, George Triadafilopoulos
• Journal: Gastroenterology report (Gastroenterol Rep (Oxf)) Vol. 3 Issue 1 Pg. 41-53 (Feb 2015) ISSN: 2052-0034 [Print] England
• PMID: 25274499 (Publication Type: Journal Article, Review)
• Copyright: © The Author(s) 2014. Published by Oxford University Press and the Digestive Science Publishing Co. Limited.